APA (7th ed.) Citation

Masarova, L., Liu, T., Fillbrunn, M., Li, W., Sajeev, G., Rao, S., . . . Signorovitch, J. (2024). Transfusion-Related Cost and Time Burden Offsets in Patients with Myelofibrosis Treated with Momelotinib in the SIMPLIFY-1 and SIMPLIFY-2 Trials. Cancers, 16(23), 4067. https://doi.org/10.3390/cancers16234067

Chicago Style (17th ed.) Citation

Masarova, Lucia, Tom Liu, Mirko Fillbrunn, Weilong Li, Gautam Sajeev, Sumati Rao, Boris Gorsh, and James Signorovitch. "Transfusion-Related Cost and Time Burden Offsets in Patients with Myelofibrosis Treated with Momelotinib in the SIMPLIFY-1 and SIMPLIFY-2 Trials." Cancers 16, no. 23 (2024): 4067. https://doi.org/10.3390/cancers16234067.

MLA (9th ed.) Citation

Masarova, Lucia, et al. "Transfusion-Related Cost and Time Burden Offsets in Patients with Myelofibrosis Treated with Momelotinib in the SIMPLIFY-1 and SIMPLIFY-2 Trials." Cancers, vol. 16, no. 23, 2024, p. 4067, https://doi.org/10.3390/cancers16234067.